Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

    Times are shown in your local time zone GMT

    Targeting peroxisomal fatty acid oxidation in advanced prostate cancer

    Presentation Description

    Institution: University of Adelaide - Adelaide, Australia

    Fatty acid oxidation (FAO) is the dominant bioenergetic pathway in prostate cancer (PCa), and is critical for cancer cell viability and redox homeostasis. While most studies have focused on mitochondrial FAO, little is known about the potential roles of peroxisomal FAO in prostate cancer, nor its relevance in disease progression or treatment resistance. Here, we aimed to evaluate the efficacy of targeting peroxisomal FAO via the clinical inhibitor thioridazine (TDZ) on prostate cancer oncogenesis.

    Authors

    Chui Yan Mah - University of Adelaide Takuto Nijiima - University of Adelaide Zeyad Nassar - University of Adelaide Lisa Butler - University of Adelaide